177 related articles for article (PubMed ID: 33490739)
21. Sudomotor dysfunction is associated with impaired left ventricular diastolic function in persons with type 2 diabetes: a cross-sectional study.
Chen X; Shui X; Xu H; Peng J; Deng H; Zhong J; Wang C; Wu J; Yan J; Yao B; Xiong Z; Xu W; Yang X
J Endocrinol Invest; 2024 Apr; 47(4):973-982. PubMed ID: 37999892
[TBL] [Abstract][Full Text] [Related]
22. Sympathetic and electrochemical skin responses in the assessment of sudomotor function: a comparative study.
Idiaquez J; Casar JC; Fadic R; Iturriaga R
Neurophysiol Clin; 2023 Apr; 53(2):102840. PubMed ID: 36716506
[TBL] [Abstract][Full Text] [Related]
23. Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.
Saad M; Psimaras D; Tafani C; Sallansonnet-Froment M; Calvet JH; Vilier A; Tigaud JM; Bompaire F; Lebouteux M; de Greslan T; Ceccaldi B; Poirier JM; Ferrand FR; Le Moulec S; Huillard O; Goldwasser F; Taillia H; Maisonobe T; Ricard D
J Neurooncol; 2016 Apr; 127(2):373-80. PubMed ID: 26749101
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
[TBL] [Abstract][Full Text] [Related]
25. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
26. Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes.
García-Ulloa AC; Almeda-Valdes P; Cuatecontzi-Xochitiotzi TE; Ramírez-García JA; Díaz-Pineda M; Garnica-Carrillo F; González-Duarte A; Narayan KMV; Aguilar-Salinas CA; Hernández-Jiménez S;
BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36521878
[TBL] [Abstract][Full Text] [Related]
27. SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy.
Selvarajah D; Cash T; Davies J; Sankar A; Rao G; Grieg M; Pallai S; Gandhi R; Wilkinson ID; Tesfaye S
PLoS One; 2015; 10(10):e0138224. PubMed ID: 26457582
[TBL] [Abstract][Full Text] [Related]
28. Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?
Rajan S; Campagnolo M; Callaghan B; Gibbons CH
Clin Auton Res; 2019 Feb; 29(1):31-39. PubMed ID: 29956008
[TBL] [Abstract][Full Text] [Related]
29. Sudomotor and cardiovascular autonomic function in de novo Parkinson's disease assessed by sudoscan and cardiovascular reflexes.
Rocchi C; Cerroni R; Conti M; Lauretti B; Mercuri NB; Stefani A; Pierantozzi M
J Neurol Sci; 2021 Aug; 427():117502. PubMed ID: 34044239
[TBL] [Abstract][Full Text] [Related]
30. [The clinical value of SUDOSCAN in diagnosis of diabetic distal symmetrical peripheral neuropathy].
Ma JJ; Hao SL; Cheng XT; Yuan Y
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1170-1174. PubMed ID: 28427125
[No Abstract] [Full Text] [Related]
31. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
32. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes.
Guo QY; Lu B; Guo ZH; Feng ZQ; Yuan YY; Jin XG; Zang P; Gu P; Shao JQ
World J Diabetes; 2020 Nov; 11(11):489-500. PubMed ID: 33269061
[TBL] [Abstract][Full Text] [Related]
33. The value of electrochemical skin conductance measurement by Sudoscan® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes.
Lefaucheur JP
Neurophysiol Clin; 2023 Apr; 53(2):102859. PubMed ID: 36966705
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive evaluation of sudomotor function in patients with myasthenia gravis.
Falcão de Campos C; Viana P; de Castro I; Castro J; de Carvalho M; Conceição I
Neurophysiol Clin; 2019 Feb; 49(1):81-86. PubMed ID: 30554965
[TBL] [Abstract][Full Text] [Related]
35. Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes.
Ang L; Jaiswal M; Callaghan B; Raffel D; B Brown M; Pop-Busui R
Auton Neurosci; 2017 Jul; 205():87-92. PubMed ID: 28325598
[TBL] [Abstract][Full Text] [Related]
36. Electrochemical skin conductance: a systematic review.
Novak P
Clin Auton Res; 2019 Feb; 29(1):17-29. PubMed ID: 28951985
[TBL] [Abstract][Full Text] [Related]
37. Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study.
Sahuc P; Chiche L; Dussol B; Pouget J; Franques J
Ther Clin Risk Manag; 2016; 12():135-8. PubMed ID: 26893567
[TBL] [Abstract][Full Text] [Related]
38. Sudomotor dysfunction in patients with gluten neuropathy.
Zis P; Shafique F; Sarrigiannis PG; Artemiadis A; Rao DG; Sanders DS; Hadjivassiliou M
Neurol Sci; 2022 May; 43(5):3381-3385. PubMed ID: 34791566
[TBL] [Abstract][Full Text] [Related]
39. The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population.
Jin J; Wang W; Gu T; Chen W; Lu J; Bi Y; Zhu D
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(8):472-477. PubMed ID: 28895640
[TBL] [Abstract][Full Text] [Related]
40. SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes.
Mao F; Liu S; Qiao X; Zheng H; Xiong Q; Wen J; Zhang S; Zhang Z; Ye H; Shi H; Lu B; Li Y
Exp Ther Med; 2017 Aug; 14(2):1343-1350. PubMed ID: 28810595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
